EP4 inhibitors and use thereof
US10973834B2 · kind B2 · utility
2Cited by
13References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 16, 2019 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Apr 16, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides use of an agent that inhibits EP4 activity and an immuno-oncology agent, or a composition thereof, for treatment of a cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.